• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 PARP1 与 FoxO1 启动子的序列特异性结合,对 FoxO1 转录进行无聚合酶依赖的抑制。

Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter.

机构信息

Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing, 100049, China.

出版信息

Cell Death Dis. 2020 Jan 28;11(1):71. doi: 10.1038/s41419-020-2265-y.

DOI:10.1038/s41419-020-2265-y
PMID:31992690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6987093/
Abstract

Poly(ADP-ribose) polymerase 1 (PARP1) regulates gene transcription in addition to functioning as a DNA repair factor. Forkhead box O1 (FoxO1) is a transcription factor involved in extensive biological processes. Here, we report that PARP1 binds to two separate motifs on the FoxO1 promoter and represses its transcription in a polymerase-independent manner. Using PARP1-knock out (KO) cells, wild-type-PARP1-complemented cells and catalytic mutant PARP1-reconstituted cells, we investigated transcriptional regulation by PARP1. PARP1 loss led to reduced DNA damage response and ~362-fold resistance to five PARP inhibitors (PARPis) in Ewing sarcoma cells. RNA sequencing showed 492 differentially expressed genes in a PARP1-KO subline, in which the FoxO1 mRNA levels increased up to more than five times. The change in the FoxO1 expression was confirmed at both mRNA and protein levels in different PARP1-KO and complemented cells. Moreover, exogenous PARP1 overexpression reduced the endogenous FoxO1 protein in RD-ES cells. Competitive EMSA and ChIP assays revealed that PARP1 specifically bound to the FoxO1 promoter. DNase I footprinting, mutation analyses, and DNA pulldown FREP assays showed that PARP1 bound to two particular nucleotide sequences separately located at -813 to -826 bp and -1805 to -1828 bp regions on the FoxO1 promoter. Either the PARPi olaparib or the PARP1 catalytic mutation (E988K) did not impair the repression of PARP1 on the FoxO1 expression. Exogenous FoxO1 overexpression did not impair cellular PARPi sensitivity. These findings demonstrate a new PARP1-gene promoter binding mode and a new transcriptional FoxO1 gene repressor.

摘要

聚(ADP-核糖)聚合酶 1(PARP1)除了作为 DNA 修复因子外,还调节基因转录。叉头框 O1(FoxO1)是一种参与广泛生物过程的转录因子。在这里,我们报告 PARP1 结合到 FoxO1 启动子上的两个独立基序上,并以聚合酶非依赖性方式抑制其转录。使用 PARP1 敲除(KO)细胞、野生型 PARP1 互补细胞和催化突变 PARP1 重建细胞,我们研究了 PARP1 的转录调节。PARP1 缺失导致 DNA 损伤反应减少,Ewing 肉瘤细胞对五种 PARP 抑制剂(PARPis)的抗性降低约 362 倍。RNA 测序显示 PARP1-KO 亚系中有 492 个差异表达基因,其中 FoxO1 mRNA 水平增加了超过五倍。在不同的 PARP1-KO 和互补细胞中,FoxO1 表达的变化在 mRNA 和蛋白质水平上均得到了证实。此外,外源性 PARP1 过表达降低了 RD-ES 细胞中的内源性 FoxO1 蛋白。竞争 EMSA 和 ChIP 测定显示 PARP1 特异性结合到 FoxO1 启动子上。DNase I 足迹分析、突变分析和 DNA 下拉 FREP 测定表明,PARP1 分别结合到 FoxO1 启动子上两个单独的核苷酸序列上,分别位于-813 到-826 bp 和-1805 到-1828 bp 区域。PARPi 奥拉帕利或 PARP1 催化突变(E988K)均不会损害 PARP1 对 FoxO1 表达的抑制作用。外源性 FoxO1 过表达不会损害细胞对 PARPi 的敏感性。这些发现表明了一种新的 PARP1-基因启动子结合模式和一种新的转录 FoxO1 基因抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/21824a45fdbf/41419_2020_2265_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/1177d964fbab/41419_2020_2265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/e0f442a24de3/41419_2020_2265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/179cc1486940/41419_2020_2265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/49cca7971530/41419_2020_2265_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/21824a45fdbf/41419_2020_2265_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/1177d964fbab/41419_2020_2265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/e0f442a24de3/41419_2020_2265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/179cc1486940/41419_2020_2265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/49cca7971530/41419_2020_2265_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b42/6987093/21824a45fdbf/41419_2020_2265_Fig5_HTML.jpg

相似文献

1
Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter.通过 PARP1 与 FoxO1 启动子的序列特异性结合,对 FoxO1 转录进行无聚合酶依赖的抑制。
Cell Death Dis. 2020 Jan 28;11(1):71. doi: 10.1038/s41419-020-2265-y.
2
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.由于 PARP1 的自身 PAR 化抑制 PARP1 在 DNA 上的结合而非 PARP1-DNA 捕获增加,与 PARP1 抑制剂的细胞毒性相关。
Int J Cancer. 2019 Aug 1;145(3):714-727. doi: 10.1002/ijc.32131. Epub 2019 Jan 30.
3
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.临床 PARP 抑制剂不能在体内 DNA 损伤部位消除 PARP1 的交换。
Nucleic Acids Res. 2020 Sep 25;48(17):9694-9709. doi: 10.1093/nar/gkaa718.
4
MORC2 regulates DNA damage response through a PARP1-dependent pathway.MORC2 通过依赖 PARP1 的途径调节 DNA 损伤反应。
Nucleic Acids Res. 2019 Sep 19;47(16):8502-8520. doi: 10.1093/nar/gkz545.
5
The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.泛素连接酶 TRIP12 限制 PARP1 捕获并限制 PARP 抑制剂的效率。
Cell Rep. 2020 Aug 4;32(5):107985. doi: 10.1016/j.celrep.2020.107985.
6
Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1.聚(ADP-核糖)聚合酶-1(PARP-1)对FOXO1介导的转录和细胞增殖的调控
Biochem Biophys Res Commun. 2009 May 8;382(3):497-502. doi: 10.1016/j.bbrc.2009.03.022. Epub 2009 Mar 10.
7
Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells.通过重建TALEN技术构建的HeLa PARP1基因敲除细胞来分析人工合成及癌症相关PARP1变体的结构-功能关系。
Nucleic Acids Res. 2016 Dec 1;44(21):10386-10405. doi: 10.1093/nar/gkw859. Epub 2016 Sep 29.
8
PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer.PARP1-DOT1L 转录轴驱动卵巢癌对 PARP 抑制剂获得性耐药。
Mol Cancer. 2024 May 22;23(1):111. doi: 10.1186/s12943-024-02025-8.
9
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
10
PARP1-siRNA suppresses human prostate cancer cell growth and progression.PARP1-siRNA 抑制人前列腺癌细胞生长和进展。
Oncol Rep. 2018 Apr;39(4):1901-1909. doi: 10.3892/or.2018.6238. Epub 2018 Jan 26.

引用本文的文献

1
Transcriptional regulation mechanism of PARP1 and its application in disease treatment.PARP1 的转录调控机制及其在疾病治疗中的应用。
Epigenetics Chromatin. 2024 Aug 8;17(1):26. doi: 10.1186/s13072-024-00550-w.
2
A Knockout of Poly(ADP-Ribose) Polymerase 1 in a Human Cell Line: An Influence on Base Excision Repair Reactions in Cellular Extracts.一个人源细胞系中聚(ADP-核糖)聚合酶 1 的敲除:对细胞抽提物中碱基切除修复反应的影响。
Cells. 2024 Feb 6;13(4):302. doi: 10.3390/cells13040302.
3
Poly(ADP-ribosyl)ating enzymes coordinate changes in the expression of metabolic genes with developmental progression.

本文引用的文献

1
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.由于 PARP1 的自身 PAR 化抑制 PARP1 在 DNA 上的结合而非 PARP1-DNA 捕获增加,与 PARP1 抑制剂的细胞毒性相关。
Int J Cancer. 2019 Aug 1;145(3):714-727. doi: 10.1002/ijc.32131. Epub 2019 Jan 30.
2
FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.FOXO1 与脑胶质瘤对化疗药物的敏感性和胶质-间质转化有关。
J Cell Biochem. 2019 Jan;120(1):882-893. doi: 10.1002/jcb.27450. Epub 2018 Sep 14.
3
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors.
聚(ADP-核糖)化酶将代谢基因表达的变化与发育进程相协调。
Sci Rep. 2023 Nov 20;13(1):20320. doi: 10.1038/s41598-023-47691-8.
4
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.EWS/FLI1 的特征、激活、抑制、靶基因及在尤文肉瘤中的治疗机会。
Int J Mol Sci. 2023 Oct 14;24(20):15173. doi: 10.3390/ijms242015173.
5
Poly(ADP-ribosyl)ating enzymes cooperate to coordinate development.多聚(ADP-核糖基)化酶协同作用以协调发育。
Sci Rep. 2022 Dec 21;12(1):22120. doi: 10.1038/s41598-022-26530-2.
6
Protective Effect of Grape Seed Proanthocyanidins on Oxidative Damage of Chicken Follicular Granulosa Cells by Inhibiting FoxO1-Mediated Autophagy.葡萄籽原花青素通过抑制FoxO1介导的自噬对鸡卵泡颗粒细胞氧化损伤的保护作用
Front Cell Dev Biol. 2022 Feb 15;10:762228. doi: 10.3389/fcell.2022.762228. eCollection 2022.
7
Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion.反复用 PARP1 和 Chk1 抑制剂处理 Capan-1 细胞会促进耐药性、迁移和侵袭。
Cancer Biol Ther. 2022 Dec 31;23(1):69-82. doi: 10.1080/15384047.2021.2024414. Epub 2022 Jan 9.
8
Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration.冈本模型的坏死及其扩展、CD38-cyclic ADP-ribose 信号系统用于细胞内 Ca 动员,以及 Reg(再生基因蛋白)-Reg 受体系统用于细胞再生。
Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(8):423-461. doi: 10.2183/pjab.97.022.
9
Novel mutations in intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors.内含子11中的新型突变以及COX-2和BIRC3的过表达介导细胞对PARP抑制剂的抗性。
Am J Cancer Res. 2020 Sep 1;10(9):2813-2831. eCollection 2020.
设计和合成 2-(4,5,6,7-四氢噻吩并[2,3-d]嘧啶-2-基)-苯并咪唑甲酰胺类新型口服有效的聚(ADP-核糖)聚合酶(PARP)抑制剂。
Eur J Med Chem. 2018 Feb 10;145:389-403. doi: 10.1016/j.ejmech.2018.01.018. Epub 2018 Jan 8.
4
Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression.磷酸酶和张力蛋白同源物缺陷型细胞通过53BP1缺失和SAMHD1过表达获得对聚(ADP - 核糖)聚合酶抑制剂和阿糖胞苷的耐药性。
Cancer Sci. 2018 Mar;109(3):821-831. doi: 10.1111/cas.13477. Epub 2018 Jan 30.
5
Re-evaluating the role of FOXOs in cancer.重新评估 FOXOs 在癌症中的作用。
Semin Cancer Biol. 2018 Jun;50:90-100. doi: 10.1016/j.semcancer.2017.11.017. Epub 2017 Nov 21.
6
The regulation of FOXO1 and its role in disease progression.FOXO1的调控及其在疾病进展中的作用。
Life Sci. 2018 Jan 15;193:124-131. doi: 10.1016/j.lfs.2017.11.030. Epub 2017 Nov 20.
7
FOXO Signaling Pathways as Therapeutic Targets in Cancer.FOXO 信号通路作为癌症治疗靶点。
Int J Biol Sci. 2017 Jul 6;13(7):815-827. doi: 10.7150/ijbs.20052. eCollection 2017.
8
Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.具有增强水溶性和体内抗癌功效的强效2,4-二氟连接子聚(ADP-核糖)聚合酶1抑制剂的发现。
Acta Pharmacol Sin. 2017 Nov;38(11):1521-1532. doi: 10.1038/aps.2017.104. Epub 2017 Aug 3.
9
Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.含2,3-二氟苯基连接基团的PARP1抑制剂的发现、作用机制及代谢研究:对癌症治疗体内疗效的增强作用
Eur J Med Chem. 2017 Sep 29;138:514-531. doi: 10.1016/j.ejmech.2017.06.053. Epub 2017 Jun 27.
10
Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors.联合53BP1与BRCA1作为生物标志物以预测聚(ADP - 核糖)聚合酶(PARP)抑制剂的敏感性。
Acta Pharmacol Sin. 2017 Jul;38(7):1038-1047. doi: 10.1038/aps.2017.8. Epub 2017 Apr 17.